Two Georgia-based companies have launched a medical cannabis shipping platform designed to help registered patients receive products at home, expanding access for people who live far from a dispensary or face barriers to traveling.

Botanical Sciences and Edibles.com announced the service November 17, describing it as the nation’s first medical cannabis shipping program.

The partnership combines Botanical Sciences’ licensed cultivation, manufacturing, and dispensing operations with Edibles.com’s e-commerce technology and digital infrastructure.

The companies’ announcement follows the Georgia Access to Medical Cannabis Commission’s September 30 adoption of Rule 351-6-.11, which established a state framework for delivery through shipping carriers.

“We helped pioneer medical cannabis access through independent pharmacies. Now we’re taking another important step forward. Georgia has created a new pathway to reach patients, and our partnership with Edibles.com allows us to translate that progress into equitable access,” said Gary Long, Chief Executive Officer of Botanical Sciences.

“Everything we do comes back to our commitment to serving Georgia patients and making medical cannabis more accessible to those who need it,” Long said.

The companies said the service is intended to help patients in rural communities, people with mobility limitations, and those facing transportation challenges obtain medical cannabis without visiting a dispensary.

“Access and accountability should never be competing priorities,” said Thomas Winstanley, President of Edibles.com and a former medical cannabis industry executive. “For too long, where a patient lives or their ability to travel has influenced their access to medical cannabis.”

“This partnership demonstrates how thoughtful regulation and technology can work together to remove those barriers without compromising the safeguards patients deserve for better quality of life. We’re proud to help Botanical Sciences bring this vision to life in our home state,” Winstanley said.

The announcement also cited comments from Andrew Turnage, Executive Director of the Georgia Access to Medical Cannabis Commission, during its September 30 meeting.

“We don’t have a dispensary in all areas of the state, but we do have patients in all areas of the state,” Turnage said, according to the release.

Orders will be handled through a separate platform incorporating patient registration verification, identity authentication, and delivery safeguards designed to meet Georgia’s requirements, the companies said.

Initially available to a select group of Botanical Sciences patients, the service is expected to expand to the company’s broader patient base, with plans to serve eligible medical cannabis patients throughout Georgia.

Botanical Sciences holds a Class 1 production license and operates a 360-acre, 133,000-square-foot cultivation and manufacturing facility in Glennville, Georgia. According to the release, its products are cultivated, processed, and tested at that facility.

Patients ordering through the platform will receive the same formulations available at Botanical Sciences dispensaries and independent pharmacy partners, the companies said.

Georgia’s delivery rule allows licensed dispensaries to deliver to registered patients, caregivers, and healthcare institutions under an approved plan. Licensees must verify identity and active registry status, retain copies of identification and registry cards, and ensure purchases comply with possession limits and restrictions on product forms.

For patients and caregivers, deliveries must go to the Georgia address on valid state-issued photo identification. The rule names the U.S. Postal Service and private carriers among permitted delivery providers.

It requires certified mail or an equivalent service with tracking and proof of delivery. Only the registered patient, caregiver, or designated healthcare institution employee may accept and sign for the shipment. Dispensaries must record proof of delivery in the state’s tracking system and document failed deliveries, with undelivered products returned to secured custody. rules.sos.ga.gov

The launch comes as Georgia’s medical cannabis program grows.

MJBizDaily reported that registered patients increased from approximately 34,500 in March to just under 65,000 as of November 4, citing Turnage’s remarks at a commission meeting.

The outlet also reported that patients began receiving products through USPS certified mail November 17 and that the companies received final state approval November 11, citing company representatives. mjbizdaily.com

Federal mailing policy remains a separate consideration.

USPS’s published shipping restrictions continue to list medical marijuana among prohibited items, while its controlled-substance mailing standards impose federal authorization requirements. While Georgia’s delivery rule establishes state authorization, it does not itself change those federal mailing standards.

Information about patient eligibility, service availability, and ordering is available at medical.edibles.com.

No more articles